Mark T. Butt

2.0k total citations
62 papers, 1.3k citations indexed

About

Mark T. Butt is a scholar working on Immunology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Mark T. Butt has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Cellular and Molecular Neuroscience and 13 papers in Physiology. Recurrent topics in Mark T. Butt's work include Immunotoxicology and immune responses (15 papers), Animal testing and alternatives (11 papers) and Nerve injury and regeneration (7 papers). Mark T. Butt is often cited by papers focused on Immunotoxicology and immune responses (15 papers), Animal testing and alternatives (11 papers) and Nerve injury and regeneration (7 papers). Mark T. Butt collaborates with scholars based in United States, United Kingdom and Australia. Mark T. Butt's co-authors include Brad Bolon, Alys Bradley, Robert H. Garman, Ingrid D. Pardo, Karl F. Jensen, Robert B. Boyd, Robert C. Sills, G. Krinke, Deepa B. Rao and Ann Radovsky and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mark T. Butt

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark T. Butt United States 22 304 297 261 248 230 62 1.3k
Naoaki Matsuki Japan 24 130 0.4× 181 0.6× 95 0.4× 384 1.5× 204 0.9× 84 1.4k
Shuichi Kobayashi Japan 25 235 0.8× 187 0.6× 75 0.3× 564 2.3× 293 1.3× 58 2.0k
Christopher L. Mariani United States 21 152 0.5× 116 0.4× 416 1.6× 195 0.8× 65 0.3× 81 1.4k
Shinji Matsuda Japan 29 482 1.6× 292 1.0× 95 0.4× 1.4k 5.8× 174 0.8× 109 2.9k
Chao Gong China 23 622 2.0× 211 0.7× 62 0.2× 724 2.9× 133 0.6× 66 2.7k
Ahmed M. Osman United States 24 110 0.4× 394 1.3× 99 0.4× 538 2.2× 64 0.3× 65 1.7k
Paul A. Cuddon United States 17 300 1.0× 42 0.1× 159 0.6× 413 1.7× 174 0.8× 30 1.4k
Jiangkai Lin China 25 422 1.4× 374 1.3× 27 0.1× 581 2.3× 136 0.6× 54 2.0k
Jin Soo Han South Korea 19 103 0.3× 125 0.4× 43 0.2× 411 1.7× 84 0.4× 67 1.2k
Katharina Spanel‐Borowski Germany 29 269 0.9× 420 1.4× 34 0.1× 813 3.3× 238 1.0× 124 2.5k

Countries citing papers authored by Mark T. Butt

Since Specialization
Citations

This map shows the geographic impact of Mark T. Butt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Butt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Butt more than expected).

Fields of papers citing papers by Mark T. Butt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Butt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Butt. The network helps show where Mark T. Butt may publish in the future.

Co-authorship network of co-authors of Mark T. Butt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Butt. A scholar is included among the top collaborators of Mark T. Butt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Butt. Mark T. Butt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Buss, Nicholas, Lisa G. Lanigan, Derek D. Cissell, et al.. (2022). Characterization of AAV-mediated dorsal root ganglionopathy. Molecular Therapy — Methods & Clinical Development. 24. 342–354. 46 indexed citations
3.
4.
Bradley, Alys, Brad Bolon, Mark T. Butt, et al.. (2020). Proliferative and Nonproliferative Lesions of the Rat and Mouse Central and Peripheral Nervous Systems: New and Revised INHAND Terms. Toxicologic Pathology. 48(7). 827–844. 20 indexed citations
5.
Sagona, Giulia, Raffaele Mazziotti, Leonardo Lupori, et al.. (2020). Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency. Scientific Reports. 10(1). 18361–18361. 14 indexed citations
6.
Butt, Mark T., Reina N. Fuji, Mike Reichelt, Alok Sharma, & Sarah D. Cramer. (2019). Autophagy of Sensory Neurons in the Trigeminal and Dorsal Root Ganglia of Cynomolgus Monkeys (Macaca fascicularis). Toxicologic Pathology. 48(1). 238–243. 10 indexed citations
7.
Butt, Mark T.. (2019). Sampling and Evaluating the Peripheral Nervous System. Toxicologic Pathology. 48(1). 10–18. 12 indexed citations
8.
Pardo, Ingrid D., Klaus Weber, Sarah D. Cramer, et al.. (2019). Atlas of Normal Microanatomy, Procedural and Processing Artifacts, Common Background Findings, and Neurotoxic Lesions in the Peripheral Nervous System of Laboratory Animals. Toxicologic Pathology. 48(1). 105–131. 21 indexed citations
9.
Bolon, Brad, Alys Bradley, Mark T. Butt, Karl F. Jensen, & Deepa B. Rao. (2019). International Regulatory Guiding Documents and Best Practice Recommendations on Peripheral Nervous System (PNS) Histopathologic Evaluation in Good Laboratory Practice (GLP)-Compliant Animal Toxicity Studies. Toxicologic Pathology. 48(1). 78–86. 9 indexed citations
11.
Butt, Mark T., et al.. (2017). Target engagement and histopathology of neuraxial resiniferatoxin in dog. Veterinary Anaesthesia and Analgesia. 45(2). 212–226. 7 indexed citations
12.
Smeyne, Richard J., Charles B. Breckenridge, Melissa J. Beck, et al.. (2016). Assessment of the Effects of MPTP and Paraquat on Dopaminergic Neurons and Microglia in the Substantia Nigra Pars Compacta of C57BL/6 Mice. PLoS ONE. 11(10). e0164094–e0164094. 78 indexed citations
13.
Minnema, Daniel J., Kim Z. Travis, Charles B. Breckenridge, et al.. (2015). Dietary administration of diquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice. Regulatory Toxicology and Pharmacology. 75. 81–88. 1 indexed citations
14.
Vuillemenot, Brian R., Derek Kennedy, Jonathan D. Cooper, et al.. (2014). Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis. Molecular Genetics and Metabolism. 114(2). 281–293. 49 indexed citations
15.
Breckenridge, Charles B., Nicholas C. Sturgess, Mark T. Butt, et al.. (2013). Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice. NeuroToxicology. 37. 1–14. 36 indexed citations
16.
Pfeifer, Richard W., Robert B. Boyd, Mark T. Butt, et al.. (2011). Safety evaluation of chronic intrathecal administration of heparan N-sulfatase in juvenile cynomolgus monkeys. Drug Delivery and Translational Research. 2(3). 187–200. 10 indexed citations
17.
Butt, Mark T.. (2009). Evaluation of the adult nervous system in preclinical studies. ˜The œbiomedical & life sciences collection.. 2009(7). e1002383–e1002383. 1 indexed citations
18.
Barr, Margaret C., et al.. (1993). Spinal lymphosarcoma and disseminated mastocytoma associated with feline immunodeficiency virus infection in a cat. Journal of the American Veterinary Medical Association. 202(12). 1978–1980. 12 indexed citations
19.
Haas, Ludwig, et al.. (1993). Engraftment of Bovine Leukemia Virus infected Lymphocytes into SCID Mice. Virology. 192(2). 655–658. 5 indexed citations
20.
Butt, Mark T.. (1990). Diagnosing erythrocyte parasitic diseases in cats.. Compendium on Continuing Education for The Practicing Veterinarian. 12(5). 628–638. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026